Form 4 for CBT CABOT CORP
Accepted 2023-11-22 00:00:00 ET · period of report 2023-11-20 · accession 0000950170-23-065861 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-11-22 | 2023-11-20 | CBT | Kalita Karen A | SVP, GC | A - Grant | $0.00 | +4,981 | 40.1K | +14% | $0 |
| D | 2023-11-22 | 2023-11-21 | CBT | Kalita Karen A | SVP, GC | S - Sale+OE | $77.78 | -22.6K | 35.2K | -39% | -$1.76M |
| D | 2023-11-22 | 2023-11-21 | CBT | Kalita Karen A | SVP, GC | M - OptEx | $40.97 | +22.6K | 57.7K | +64% | +$924.9K |
| D | 2023-11-22 | 2023-11-20 | CBT | Kalita Karen A | SVP, GC | F - Tax | $77.89 | -4,902 | 35.2K | -12% | -$381.8K |
| D | 2023-11-22 | 2023-11-21 | CBT | Kalita Karen A | SVP, GC | M - OptEx | $0.00 | -22.6K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-20 | A | A | 4,981 | $0.00 | 40,069 | D | — | — | (F1) Consists of performance based units earned on the basis of the Corporation's performance in fiscal year 2023, of which 1,421 remain subject to time-based vesting. |
| 2 | Common | Common Stock | 2023-11-21 | S | D | 22,574 | $77.78 | 35,167 | D | — | — | (F2) The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $77.760 to $77.950, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the Corporation or any security holder of the Corporation, upon request, full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2023-11-21 | M | A | 22,574 | $40.97 | 57,741 | D | — | — | |
| 4 | Common | Common Stock | 2023-11-20 | F | D | 4,902 | $77.89 | 35,167 | D | — | — | |
| 5 | Derivative | Employee Stock Option (Right to Buy) | 2023-11-21 | M | D | 22,574 | $0.00 | 0 | D | $40.97 · — to 2030-11-12 | 22,574 Common Stock | (F3) 22,574 shares were subject to the option. The option vested over a three year period as follows: 30% on November 13, 2021, 30% on November 13, 2022 and 40% on November 13, 2023. |